U.S. markets closed
  • S&P 500

    3,380.80
    +17.80 (+0.53%)
     
  • Dow 30

    27,816.90
    +35.20 (+0.13%)
     
  • Nasdaq

    11,326.51
    +159.00 (+1.42%)
     
  • Russell 2000

    1,531.20
    +23.51 (+1.56%)
     
  • Crude Oil

    38.63
    -1.59 (-3.95%)
     
  • Gold

    1,910.60
    +15.10 (+0.80%)
     
  • Silver

    23.89
    +0.40 (+1.69%)
     
  • EUR/USD

    1.1754
    +0.0028 (+0.24%)
     
  • 10-Yr Bond

    0.6770
    0.0000 (0.00%)
     
  • GBP/USD

    1.2883
    -0.0038 (-0.29%)
     
  • USD/JPY

    105.5270
    +0.0970 (+0.09%)
     
  • BTC-USD

    10,620.47
    -175.56 (-1.63%)
     
  • CMC Crypto 200

    227.77
    +4.07 (+1.82%)
     
  • FTSE 100

    5,879.45
    +13.35 (+0.23%)
     
  • Nikkei 225

    23,185.12
    0.00 (0.00%)
     

Cannabis Countdown: Top 10 Marijuana And Psychedelics Industry News Stories Of The Week

The Cannabis Investor

Welcome to the Cannabis Countdown. In This Week’s Edition, We Recap and Countdown the Top 10 Marijuana and Psychedelics Industry News Stories for the Week of August 3rd – 9th, 2020.

Without further ado, let’s get started.

Yahoo Finance readers, please click here to view full article.

10. Canada Approves the Use of Psilocybin Mushrooms for Terminally Ill Patients

Back in April, the Four Cancer Patients Petitioned the Canadian Health Minister for Permission to Use Psilocybin as Part of Their Psychotherapy Treatment

In a landmark decision by Canada’s Minister of Health, the Honourable Patty Hajdu, four terminally ill cancer patients receiving end-of-life care will be legally allowed to carry and consume Psilocybin mushrooms, commonly referred to as Magic Mushrooms.

READ FULL CANADA PSILOCYBIN ARTICLE

9. From Green Bay to Green Eagle: Brett Favre Joins CBD Innovator as Brand Ambassador

NFL Hall of Famer Brett Favre Has Officially Joined the CBD Industry

The long-time Green Bay Packers quarterback has signed on to be a brand ambassador for Green Eagle, a new CBD brand that makes creams, roll-ons, sprays, liquid capsules and salve sticks.

READ FULL BRETT FAVRE ARTICLE

8. It’s Official: Washington D.C. Psychedelics Initiative Qualifies for the November 2020 Ballot

It Was Announced That Enough Valid Signatures Were Collected in D.C. to Place the Wide-Ranging Psychedelics Decriminalization Measure on the November 2020 Ballot

During a virtual meeting this week, the Washington D.C. Board of Elections confirmed the news via a certification announcement, which means that in just a few short months, D.C. voters will have the final say in this historic opportunity for drug reform. If approved, the “I-81” initiative would make Psychedelic substances such as Ayahuasca, Ibogaine, and Psilocybin in line with the lowest law enforcement concerns in D.C.

READ FULL D.C. PSYCHEDELICS ARTICLE

7. Senator Touts New Marijuana Legalization Bill in Floor Speech on Racial Justice

Sen. Tina Smith (D-MN) Talked Up Her New Marijuana Legalization Bill During a Speech on Racial Justice That She Delivered on the Senate Floor

The senator, whose “Substance Regulation and Safety Act” was introduced late last month, said that ending cannabis prohibition could help law enforcement devote more resources to serious crimes, rather than continue to criminalize people in a racially disparate manner.

READ FULL MARIJUANA LEGALIZATION ARTICLE

6. Better Development Tools for a New Golden Era of Psychopharmacology

The Global Pharmaceuticals Market is Expected to Be Worth $1.57 Trillion by 2023, with the U.S. Claiming a 45.33% Market Share

There is a renaissance in pharmacology today, a sort of golden era inspired by both the need to expedite the creation of a vaccine to treat a global pandemic, and medicalizing treatments of other conditions such as mental health with Psychedelics. The surge of growth in pharmaceuticals is eye-popping.

READ FULL PSYCHOPHARMACOLOGY ARTICLE

5. Illinois Shatters Marijuana Sales Record with Nearly 1.3 Million Products Sold in July

Illinois Saw Another Record-Breaking Month of Recreational Cannabis Sales in July

Despite the coronavirus pandemic, Illinois is reporting nearly $61 million in adult-use Cannabis sales—smashing the previous record set in June of nearly $47 million. For the first time, more than one million Marijuana items—1,270,063 to be precise—were purchased in a monthly reporting period.

READ FULL ILLINOIS CANNABIS ARTICLE

4. Oregon Officials Explain How Decriminalized Drugs and Legal Psilocybin Therapy Would Impact the State

Overall, the Policy Change Would Result in a 95% Drop in Racial Disparities for Possession Arrests, the Panel Projects

Oregon officials finalized a series of analyses on separate ballot measures to legalize Psilocybin mushrooms for therapeutic use and decriminalize drugs while investing in substance misuse treatment.

READ FULL OREGON PSILOCYBIN ARTICLE

3. Local Ballot Measures Across California Could Significantly Expand Marijuana Industry Footprint

The November Election Offers the Prospect That California’s Legal Cannabis Industry Footprint Could Expand Significantly, Depending on a Many Local Ballot Measures

According to research by Hirsh Jain, government affairs director at San Jose-based retailer Caliva, and California NORML Deputy Director Ellen Komp, at least 26 localities across California will have pro-marijuana initiatives on the ballot. Jain estimates those measures could result in as many as 150 new business permits being made available to the industry.

READ FULL CALIFORNIA CANNABIS ARTICLE

2. Revive Therapeutics Just Became a Serious Player in the Race to Treat COVID-19

Revive Received the FDA Sign Off to Start a Phase 3 Trial on Bucillamine for Mild to Moderate Cases of COVID-19

Revive Therapeutics (OTCPK: RVVTF) is a Canadian life sciences company focused on the research and development of therapeutics for infectious diseases and rare disorders. It began the year hot as it was fully onboard the psilocybin craze before Psychedelic Stocks like itself, Champignon Brands (OTCQB: SHRMF) and MindMed (OTCQB: MMEDF) pulled back from their highs.

READ FULL REVIVE ARTICLE

1. Acreage, Curaleaf, Trulieve And More: Here Are The Cannabis Companies Currently Hiring

The U.S. Labor Department Will Release its Employment Report and While Job Growth Appeared Evident Over the Past Two Months, Economists Are Worried That the Trend Has Fizzled Out in Recent Weeks

However, hiring is still happening in the cannabis sector. Here’s a list of companies currently on the hunt for talent: Curaleaf (OTCQX: CURLF)Trulieve (OTCQX: TCNNF)Green Thumb (OTCQX: GTBIF), Cresco Labs, Acreage Holdings (OTCQX: ACRGF)Aphria (NYSE: APHA)Harvest Health (OTCQX: HRVSF), iAnthus (OTCQX: ITHUF)MedMen (OTCQX: MMNFF)4Front Ventures (OTCQX: FFNTF) and Terra Tech (OTCQX: TRTC).

READ FULL CANNABIS HIRING ARTICLE

Photo by Matteo Paganelli on Unsplash

See more from Benzinga

© 2020 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.